anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Source Note

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 110,355
Current window 49,231-49,260
Pages 3,679
Rows per page 30
Component: Source Noteclear collectionreset all
18 30 60

Component

49,231-49,260 of 110,355

filter-aware
50
The slide uses a callout box to summarize the performance metrics relative to the short position inception.Pershing Square Portfolio (multiple positions) · Pershing Square
Activist deck Activist investor Beat · The Breakthrough1 hit
51
The slide uses a red box to highlight North America and Mexico as the primary drivers of the decline.Pershing Square Portfolio (multiple positions) · Pershing Square
Activist deck Activist investor Beat · Ultimate Achievement1 hit
52
The chart shows the composition of Enterprise Value, highlighting the increase in Gross Debt relative to Diluted Market Capitalization.Pershing Square Portfolio (multiple positions) · Pershing Square
Activist deck Activist investor Beat · Ultimate Achievement1 hit
56
The slide uses a green table to contrast goals with outcomes, using checkmarks for success and an 'x' for the failure to trade at a premium.Pershing Square Portfolio (multiple positions) · Pershing Square
Activist deck Activist investor Beat · Ultimate Achievement1 hit
60
The chart shows the stock price (blue) consistently trading below the NAV (green).Pershing Square Portfolio (multiple positions) · Pershing Square
Activist deck Activist investor Beat · Ultimate Achievement1 hit
61
The chart highlights a significant disparity between broker-traded and exchange-traded volumes, with a dashed line indicating the weekly average.Pershing Square Portfolio (multiple positions) · Pershing Square
Activist deck Activist investor Beat · Ultimate Achievement1 hit
05
This slide appears to be from an activist presentation (likely Pershing Square's Herbalife deck) used to establish the company's expansion history.Herbalife, Ltd. (HLF) · William Ackman
Activist deck Activist investor Beat · The Call1 hit
06
The slide uses a CEO quote to frame the company's strategy in China as recruitment-heavy, likely to support an argument about pyramid scheme characteristics.Herbalife, Ltd. (HLF) · William Ackman
Activist deck Activist investor Beat · The Monster1 hit
07
The slide uses a table to demonstrate the increasing reliance on the Chinese market.Herbalife, Ltd. (HLF) · William Ackman
Activist deck Activist investor Beat · The Monster1 hit
03
The chart uses a timeline-based annotation style to correlate M&A activity with stock performance.Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor 1 hit
04
The chart demonstrates long-term market mispricing of earnings growth potential.Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor 1 hit
05
This slide provides a high-level company profile and performance summary.Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor 1 hit
06
The chart uses callout boxes to correlate specific acquisition announcements with share price movements.Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor 1 hit
07
Valeant Pharmaceuticals International (VRX)Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor 1 hit
08
The chart uses callouts to annotate specific events (IPO and acquisition announcement) that correlate with share price movements.Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor 1 hit
12
Valeant Pharmaceuticals International (VRX)Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor Loop · Logic Chain1 hit
15
The chart uses a 4,502% return figure to illustrate the ~45x growth mentioned in the action title.Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor Loop · Logic Chain1 hit
17
The slide outlines the core pillars of Valeant's M&A success.Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor Loop · Logic Chain1 hit
19
Valeant Pharmaceuticals International (VRX)Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor Loop · Logic Chain1 hit
21
The slide uses callout boxes to correlate specific corporate events with stock price movements.Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor Loop · Logic Chain1 hit
22
The chart illustrates the 'multiple expansion' of Valeant's stock relative to a fixed future earnings consensus.Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor Loop · Logic Chain1 hit
26
The slide uses a 'However' transition to pivot from a standard valuation to a more complex, asset-based argument.Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor Beat · Solution1 hit
27
The slide uses a structured table format to justify valuation inputs for an acquisition model.Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor Beat · Solution1 hit
30
The slide uses a 10% discount rate for PV calculations and assumes a constant 16x NTM P/E multiple.Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor Beat · Solution1 hit
37
The slide uses specific financial metrics (EBITA, Gross Margin, Forward EPS) to establish a peer benchmark for Valeant's portfolio durability.Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor 1 hit
38
The table includes a calculated average row at the bottom.Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor 1 hit
40
The slide justifies using non-healthcare benchmarks for valuation by highlighting similar margin and growth profiles.Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor 1 hit
41
The slide uses a bar chart to establish a valuation benchmark for non-healthcare sectors.Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor 1 hit
44
The slide uses a bridge framework to reconcile 2015 revenue to 2020 estimates for cliff products.Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor 1 hit
45
The slide provides specific financial modeling parameters for Valeant and Salix, excluding future acquisitions.Valeant Pharmaceuticals International (VRX) · William Ackman
Conference presentation Activist investor 1 hit